PKG00249727-instructions..pdf

U.S. Department of Justice Office of Justice Programs Bureau of Justice Assistance

OMB No. 1121-0329 Approval Expires 11/30/2020

The U.S. Department of Justice (DOJ), Office of Justice Programs (OJP), Bureau of Justice Assistance (BJA) is seeking applications to plan and implement comprehensive programs in response to the growing opioid epidemic. This program furthers the Department’s mission by providing resources to support state, local, tribal, and territorial efforts to reduce violent crime and drug abuse and enhance public safety, while supporting victims.

Comprehensive Opioid Abuse Site-based Program

FY 2019 Competitive Grant Announcement Applications Due: June 5, 2019

Eligibility

Eligible applicants are those that meet the following criteria for the three categories:

Category 1: Locally Driven Responses to the Opioid Epidemic – Applicants are limited to units of local government and federally recognized Indian tribal governments (as determined by the Secretary of the Interior). Jurisdictions without a county- or local government-based addiction service system may designate the State Administering Agency (SAA) to serve as the primary applicant and subgrant funds to providers at the county level. Applicants should ensure they apply under the appropriate subcategory based on the population of the proposed project area.

Subcategory 1a – An urban area or large county with a population greater than 500,000.

Subcategory 1b – A suburban area or medium-size county with a population between 100,000 and 500,000.

Subcategory 1c – A rural area or small county with a population of fewer than 100,000 or a federally recognized Indian tribe.

Category 2: Statewide Implementation, Enhancement, and Evaluation Projects – Applicants are limited to the SAA responsible for directing criminal justice planning or the State Alcohol and Substance Abuse Agency.

Category 3: Harold Rogers Prescription Drug Monitoring Program (PDMP) Implementation and Enhancement Projects – Applicants are limited to state governments and territories that have a pending or enacted enabling statute or regulation requiring the submission of controlled substance prescription data to an authorized state agency. Applicants http://www.justice.gov/ https://ojp.gov/ https://www.bja.gov/ https://www.bja.gov/ https://ojp.gov/saa/

BJA-2019-15111

within a state that does not have an enabling state statute requiring the submission of controlled substance prescription data to an authorized state agency are eligible to apply as a city, county, or region if (a) the city, county, or region has enacted an enabling statute, ordinance, or regulation requiring the submission of controlled substance prescription data to an authorized city, county, or region; (b) the city, county, or region agrees to transition the PDMP system to an authorized state agency if the state adopts an enabling state statute requiring the submission of controlled substance prescription data to an authorized state agency; and (c) the city, county, or region ensures that all vendor contracts are written to permit the transfer of ownership of the system to the authorized state agency.

For any of the categories listed above, BJA welcomes applications under which two or more entities would carry out the federal award; however, only one entity may be the applicant. Any others must be proposed as subrecipients (“subgrantees").1 The applicant must be the entity that would have primary responsibility for carrying out the award, including administering the funding and managing the entire project.

For each category, only one application by any particular applicant entity will be considered. An entity may, however, be proposed as a subrecipient (subgrantee) in more than one application.

This includes applications that propose to serve a region that crosses state boundaries.

Subrecipients may include treatment providers, victim service providers, and other not-for-profit entities as part of a comprehensive cross-disciplinary response as outlined in Categories 1 and

2. If an agency wishes to apply under multiple categories, a separate application is needed for each category of funding.

BJA may elect to fund applications submitted under this FY 2019 solicitation in future fiscal years, dependent on, among other considerations, the merit of the applications and on the availability of appropriations.

Deadline

Applicants must register with Grants.gov at https://www.grants.gov/web/grants/register.html prior to submitting an application. All applications are due by 11:59 p.m. eastern time on June 5, 2019.

To be considered timely, an application must be submitted by the application deadline using Grants.gov, and the applicant must have received a validation message from Grants.gov that indicates successful and timely submission. OJP urges applicants to submit applications at least 72 hours prior to the application due date, to allow time for the applicant to receive validation messages or rejection notifications from Grants.gov, and to correct in a timely fashion any problems that may have caused a rejection notification.

OJP encourages all applicants to read this Important Notice: Applying for Grants in Grants.gov.

For additional information, see How To Apply in Section D. Application and Submission Information.

1 For additional information on subawards, see "Budget and Associated Documentation" under Section D. Application and Submission Information.

https://www.grants.gov/web/grants/register.html http://ojp.gov/funding/Apply/Grants-govInfo.htm

Contact Information

For technical assistance with submitting an application, contact the Grants.gov Customer Support Hotline at 800-518-4726 or 606-545-5035, at https://www.grants.gov/web/grants/support.html, or via email to support@grants.gov. The Grants.gov Support Hotline hours of operation are 24 hours a day, 7 days a week, except on federal holidays.

An applicant that experiences unforeseen Grants.gov technical issues beyond its control that prevent it from submitting its application by the deadline must email the contact identified below within 24 hours after the application deadline to request approval to submit its application after the deadline. Additional information on reporting technical issues appears under “Experiencing Unforeseen Grants.gov Technical Issues” in the How To Apply section.

For assistance with any unforeseen Grants.gov technical issues beyond an applicant’s control that prevent it from submitting its application by the deadline, or any other requirement of this solicitation, contact the National Criminal Justice Reference Service (NCJRS) Response Center:

toll-free at 800–851–3420; via TTY at 301–240–6310 (hearing impaired only); email grants@ncjrs.gov; fax to 301–240–5830; or web chat at https://webcontact.ncjrs.gov/ncjchat/chat.jsp. The NCJRS Response Center hours of operation are 10:00 a.m. to 6:00 p.m. eastern time, Monday through Friday, and 10:00 a.m. to 8:00 p.m.

eastern time on the solicitation close date.

Grants.gov number assigned to this announcement: BJA-2019-15111

Release date: April 5, 2019 https://www.grants.gov/web/grants/support.html mailto:support@grants.gov mailto:grants@ncjrs.gov https://webcontact.ncjrs.gov/ncjchat/chat.jsp

Contents A. Program Description

Overview

Program-specific Information

Objectives and Deliverables

Evidence-based Programs or Practices

Information Regarding Potential Evaluation of Programs and Activities

B. Federal Award Information

Type of Award

Financial Management and System of Internal Controls

Budget Information

Cost Sharing or Match Requirement

Pre-agreement Costs (also known as Pre-award Costs)

Limitation on Use of Award Funds for Employee Compensation; Waiver

Prior Approval, Planning, and Reporting of Conference/Meeting/Training Costs

Costs Associated with Language Assistance (if applicable)

C. Eligibility Information

D. Application and Submission Information

What an Application Should Include

How To Apply

E. Application Review Information

Review Criteria

Review Process

F. Federal Award Administration Information

Federal Award Notices

Administrative, National Policy, and Other Legal Requirements

General Information about Post-Federal Award Reporting Requirements

G. Federal Awarding Agency Contact(s)

H. Other Information

Freedom of Information Act and Privacy Act (5 U.S.C. 552 and 5 U.S.C. 552a)

Provide Feedback to OJP

Appendix A: Application Checklist

Comprehensive Opioid Abuse Site-based Program

CFDA #16.838 (Categories 1 and 2) and CFDA #16.754 (Category 3)

A. Program Description

Overview The Comprehensive Opioid Abuse Site-based Program (COAP) was developed as part of the Comprehensive Addiction and Recovery Act (CARA) legislation. COAP’s purpose is to provide financial and technical assistance to states, units of local government, and Indian tribal governments to plan, develop, and implement comprehensive efforts to identify, respond to, treat, and support those impacted by the opioid epidemic. The Harold Rogers Prescription Drug Monitoring Program (PDMP) has been incorporated into the FY 2019 COAP solicitation. The purpose of the Harold Rogers PDMP is to improve collaboration and strategic decision making among regulatory and law enforcement agencies and public health entities to address prescription drug and opioid abuse, save lives, and reduce crime.

Statutory Authority 34 U.S.C. 10701 and Pub. L. No. 116-6, 133 Stat 13, 114.

Program-specific Information The opioid crisis is a public health emergency that threatens the wellbeing of individuals who abuse drugs and impacts the safety of communities. It is impacting first responders, the criminal justice system, child welfare and foster care, and behavioral health systems. Responding to this epidemic is one of DOJ’s top priorities. Since 2017, BJA has supported innovative work in over 200 COAP sites. Examples of successful BJA-funded COAP projects can be found at:

https://www.coapresources.org/#COAPHOME.

Objectives and Deliverables COAP aims to reduce opioid abuse and the number of overdose fatalities, as well as to mitigate the impacts on crime victims by supporting comprehensive, collaborative initiatives. The program also supports the implementation, enhancement, and proactive use of PDMPs to support clinical decision making and prevent the abuse and diversion of controlled substances.

Grantees are prohibited from using federal funds to support activities that violate the Controlled Substances Act.

Mandatory Project Components of Categories 1 and 2 Applicants applying for funding under Categories 1 or 2 must:

• Agree to work closely with BJA’s designated training and technical assistance (TTA) provider(s) that may assist with planning, implementation, and assessment of the sites.

• Agree to work closely with a researcher selected by BJA who may conduct a site-specific or cross-site evaluation in future years.

• Identify a project coordinator to manage the day-to-day operations of the initiative.

The project coordinator should devote at least 50 percent of his or her time to the https://www.coapresources.org/#COAPHOME proposed project and may be funded as part of the proposed project.

Category 1: Locally Driven Responses to the Opioid Epidemic The objective of Category 1 is to encourage and support the development of comprehensive, locally driven responses to the opioid epidemic that expand access to supervision, treatment, and recovery support services across the criminal justice system; support law enforcement and other first responder diversion programs for non-violent drug offenders; promote education and prevention activities; and address the needs of children impacted by the opioid epidemic. All projects are expected to involve multiple agencies and partners.

Allowable Uses of Category 1 Funds Category 1 grant funds, regardless of the subcategory, may be used to support a combination of the allowable use activities described below, or be concentrated on one, so long as the proposed budget is appropriate and justified:

• Establish pre-arrest or post-arrest law enforcement or other first-responder diversion programs for individuals who commit low level, non-violent, drug-related offenses to community-based substance abuse and behavioral health services. Jurisdictions seeking to replicate a branded model of law enforcement diversion, such as the Law Enforcement Assisted Diversion (LEAD) model or Police Assisted Addiction and Recovery Initiative (PAARI), should familiarize themselves with the goals and core principles of the model and reflect these concepts in their applications. BJA supports a wide variety of diversion models that promote public safety and public health collaboration. OJP anticipates a minimum of $5 million in COAP funds will be used to support communities seeking to replicate the LEAD model per Congressional report language.

• Support law enforcement agencies in identifying individuals in need of substance abuse treatment services and connecting these individuals to treatment services. A variety of approaches may be proposed including embedding substance abuse clinicians into patrol units or increasing a law enforcement agency’s analytic capability by hiring data analysts or epidemiologists. In areas where human trafficking is prevalent, law enforcement agencies may propose projects to strengthen the connection between human trafficking taskforces and substance abuse treatment providers.

• Develop programs that embed social services with law enforcement in order to rapidly respond to opioid overdoses where children are impacted. Examples of services that may be included are: Co-locating staff to assist with screening, assessment, referral, and/or the provision of services to children and families impacted by substance abuse;

Implementing a combination of evidence-based or evidence-informed programs and practices, including parenting and/or family strengthening, treatment for trauma or mental health problems, counseling and peer support groups, and child development services designed to support children and youth exposed to drug use and their caregivers; Developing specialized training to first responders, victim service providers, and child protective services professionals to ensure that there is an established process/protocol to follow when encountering a child or youth affected by overdose or in a home where the child is exposed to substance abuse; Supporting cross-system collaborative activities (e.g., multidisciplinary training, regular partnership meetings) to increase understanding among the different service systems about issues facing families involved in child protective services due to a parent’s substance abuse; and, Providing training and information on resources to child and youth-serving organizations, such as schools, athletic leagues and faith-based organizations, on the impact of substance abuse on children, youth, and families. As directed by Congress, a minimum of $10 million in COAP funds will be made available for this purpose. Efforts that involve serving children may be jointly supported by BJA in partnership with the Office for Victims of Crime (OVC).

• Connect individuals at risk for overdose and/or survivors of a non-fatal overdose and their families with substance abuse and behavioral health treatment providers or peer recovery support providers trained in addiction support and recovery. “Peers” may include, but are not limited to, peer mentors, peer navigators, forensic peers, and family members of those in recovery.

• Provide transitional or recovery housing as part of a comprehensive response strategy.

No more than 30 percent of total grant funds may be used for this purpose.

• Establish court-based intervention programs or family court programming to prioritize and expedite treatment and recovery services to individuals at high risk for overdose.

Funding is available under other BJA solicitations to implement or enhance an adult drug court and/or a veteran treatment court. As such, implementing or enhancing these court models is not an allowable funding activity under this solicitation.

• Develop, implement, or enhance programs to address the opioid epidemic in rural or tribal communities. Applicants may use technology to expand access to treatment and recovery support services for individuals who abuse illicit and prescription opioids and have limited access to treatment and recovery services due to geographic isolation.

• Purchase and distribute tamper-proof drug-collection boxes and other federally approved controlled substance collection and permanent disposal programs. OJP anticipates a minimum of $10 million in COAP funds will be made available for this purpose per congressional report language.

• Develop and implement a comprehensive plan to reduce the risk of overdose death and enhance treatment and recovery service engagement among the pretrial and post-trial populations leaving jails or secure residential treatment facilities. This includes implementing medication-assisted treatment and cognitive behavioral treatment within a local or regional jail and supporting the transition to community-based services once released from custody. Applicants must demonstrate strong coordination between in-custody and community-based treatment as part of the application.

• Implement an overdose fatality review team (that includes representation from medical examiner or coroner offices) and/or support multidisciplinary intervention models such as New York City’s RxStat Program (http://www.pdmpassist.org/pdf/RxStat.pdf) to bring together stakeholders with different perspectives and different data sets.

• Support the timely collection of data and/or data integration with other data sets (such as PDMP records) to provide an understanding of drug trends, support program evaluation, inform clinical decision making, identify at-risk individuals or populations, or support investigations. Examples of data sources may include medical examiner and coroner offices, forensic science laboratories, crime scene units (such as data related to the analysis of suspected controlled substances and toxicology analysis), or other novel sources of information such as testing used needles from syringe exchange programs to understand the current local drug supply. Grant funds may be used to upgrade, lease, or purchase equipment or case/information management systems only to the extent the applicant clearly articulates how the equipment or case/information management systems will expedite access to data or data integration that will be used as part of a comprehensive strategy. Applications must clearly articulate how the proposed collection of data or data integration efforts are part of a larger collaborative effort with multiple project partners. Applications solely for equipment or case/information management system upgrades, leases, or purchases will not be considered.

• Implement other comprehensive approaches that align with the objectives of COAP.

http://www.pdmpassist.org/pdf/RxStat.pdf

Mandatory Project Components of Category 1 Applicants applying for funding under Category 1 must propose to implement one or more of the allowable activities outlined above and outline a comprehensive, collaborative approach to addressing the opioid epidemic.

Mandatory Deliverables of Category 1 Applicants applying for funding under Category 1 must:

• Implement the proposed project within 9 months of the award.

• Document the implementation of the program in a manual that includes policies and procedures, forms, and other relevant project materials and provide this to BJA for inclusion on the COAP Resource Center no later than 24 months from the time of the award.

• If an evaluation is proposed, provide a copy of any evaluation report funded under the project prior to the close of the grant period.

Category 2: Statewide Implementation, Enhancement, and Evaluation Projects The objective of Category 2 is to support states in their efforts to implement, enhance, or evaluate effective opioid-related efforts within the criminal justice system. Applicants should clearly indicate in their applications whether they are applying for Subcategory 2a, Subcategory 2b, or Subcategory 2c (which is both 2a and 2b). A description of each subcategory is below.

Subcategory 2a: Statewide Implementation Projects State applicants may request up to $5,000,000 to implement new opioid-intervention programs in a minimum of six geographically diverse localities or regions within the state or $3,000,000 to implement new opioid-intervention programs in a minimum of three geographically diverse localities or regions within the state. Project funds in 2a should be focused on implementing new programs, not enhancing existing programs.

Allowable Uses of Subcategory 2a Funds The state may select one or more of the allowable activities detailed under the Allowable Uses of Funds section of Category 1 and support their implementation. For example, a state may propose to implement six new law enforcement diversion programs and overdose fatality review teams across the state.

Mandatory Project Components for Subcategory 2a Applicants applying for funding under Subcategory 2a must:

• Propose to implement one or more of the allowable activities outlined in Category 1 in a minimum of three sites.

• If the state proposes to implement projects in three to five sites, up to $400,000 may be retained by the state for administrative purposes and to support the mandatory deliverables. If the state proposes to implement projects in six or more sites, up to $800,000 may be retained by the state for administrative purposes and to support the mandatory deliverables. The remaining federal funds under Subcategory 2a must be passed through to the proposed project sites. States that have no county or local government-managed addiction service system may contract funds directly to providers at the community level.

• Outline a comprehensive, collaborative approach to addressing the opioid epidemic.

Mandatory Deliverables for Subcategory 2a

• Select and subaward to a minimum of three geographically diverse localities or regions within the state within 9 months of the grant award.

• Support a robust planning period for the sites of no longer than 4 months and support implementation efforts at each of the sites.

• Coordinate cross-site training and peer-to-peer learning.

• Document the implementation of the programs in a manual that includes policies and procedures, forms, and other relevant project materials and provide this to BJA for inclusion on the COAP Resource Center no later than 24 months after the time of the award.

• Produce an annual brief on the status of each program site, summarizing the key performance indicators.

Subcategory 2b. Statewide Enhancement or Evaluation State applicants must enhance or evaluate existing opioid-intervention programs in a minimum of three geographically diverse localities or regions within the state.

Allowable Uses of Subcategory 2b Funds Applicants may propose to enhance, expand, and/or evaluate existing opioid-related activities by providing training and/or technical assistance; expanding successful programs to additional sites; adding additional components to existing programs to strengthen the program’s impact;

assessing the impact of specific policy or practice changes on patient/client level or community-level outcomes; or conducting a multisite evaluation of established opioid-intervention programs in the state.

Mandatory Project Components for Subcategory 2b

• Propose to implement one or more of the allowable activities described under Category 1.

• Retain up to $200,000 for administrative purposes and to support the mandatory deliverables.

Mandatory Deliverables for Subcategory 2b

• Select and subaward to a minimum of three geographically diverse localities or regions (depending on the funding amount requested) within the state within 9 months.

• If the proposed project is an enhancement or expansion project, develop a manual that includes policies and procedures, forms, and other relevant project materials and provide this to BJA for inclusion on the COAP Resource Center no later than 24 months after the time of the award.

• If the proposed project is an enhancement or expansion project, produce an annual brief on the status of each project site, summarizing key performance indicators.

• If the proposed project is an evaluation, provide a copy of any evaluation report funded under Subcategory 2b prior to the close of the grant period.

Subcategory 2c. A state that would like to implement new initiatives and enhance or evaluate existing initiatives may apply for both Subcategories 2a and 2b. If you would like to apply for both Subcategories 2a and 2b, label your application as “Subcategory 2c” and include all the necessary components of both subcategories in the single application.

Category 3: Harold Rogers PDMP Implementation and Enhancement Projects The objective of Category 3 is to strengthen the nation’s PDMP system and support enhancements to PDMPs that improve clinical decision making and prevent the abuse and diversion of controlled substances.

Allowable Uses of Funds for Category 3 Grant funds may be used to establish or enhance a PDMP system; facilitate the exchange of information and collection of data on prescriptions and other scheduled chemical products among states; develop a training program for system users; produce and disseminate educational materials; support collaborations among law enforcement, prosecutors, public health officials, treatment providers, and/or drug courts; facilitate electronic information sharing among states in compliance with the Prescription Monitoring Information Exchange (PMIX) National Architecture; expand monitoring to Schedules II, III, IV, and V; improve the quality and accuracy of PDMP data; develop or enhance the capacity to provide unsolicited reports of controlled substance prescribing to authorized individuals or entities; and/or assess the efficiency and effectiveness of the PDMP program or specific PDMP initiatives.

Mandatory Project Components and Deliverables for Category 3

• Agree to work closely with BJA’s designated TTA provider(s).

• Use technical solutions that are compliant with the PMIX National Architecture if requesting funds to implement information sharing with other state PDMPs.

Documentation regarding compliance with this requirement should be included in the application. For instance, if an interstate data-sharing hub has been certified as PMIX compliant, include this information. Absent such information, BJA will withhold funding for such purposes until compliance can be verified. For more information on the National PMIX Architecture, visit the PDMP Training and Technical Assistance Center’s website at http://www.pdmpassist.org/content/prescription-drug-monitoring-information-architecture-pmix.

• Ensure that the recipient’s PDMP system has the capacity to exchange data with other PDMP systems via the PDMP hub, which is the RxCheck hub. Category 3 applicants that are not already actively connected to the RxCheck hub may include the cost of connecting, if any, in their budget request. Additional information about this requirement may be found at https://www.coapresources.org/Content/Documents/pdmpDataSharing/COAP_PDMP_S pecialConditions.pdf.

Mandatory Project Component for Projects that Propose Data Collection, Aggregation, and Sharing Any organization using OJP grant funds, in whole or in part, to collect, aggregate, and/or share data must guarantee that the agency that owns the data and its approved designee(s) will retain unrestricted access to the data, in accordance with all applicable laws, regulations, and BJA policy. This includes providing data (a) in an expeditious manner upon request by BJA; (b) in a clearly defined format that is open, user-friendly, and unfettered by unreasonable proprietary restrictions; and (c) at a minimal additional cost to the requestor (which cost may be borne by using grant funds).

Interagency Coordination OJP administers the Harold Rogers PDMP in partnership and collaboration with the Centers for Disease Control (CDC) and the Substance Abuse and Mental Health Services Administration (SAMHSA)’s Center for Substance Abuse Treatment and is cognizant of the importance of PDMPs to the Drug Enforcement Agency (DEA) Office of Diversion Control and the Office of http://www.pdmpassist.org/content/prescription-drug-monitoring-information-architecture-pmix http://www.pdmpassist.org/content/prescription-drug-monitoring-information-architecture-pmix https://www.coapresources.org/Content/Documents/pdmpDataSharing/COAP_PDMP_SpecialConditions.pdf https://www.coapresources.org/Content/Documents/pdmpDataSharing/COAP_PDMP_SpecialConditions.pdf

National Drug Control Policy (ONDCP). Similarly, OJP is cognizant of the importance of all other COAP programs and projects to the agencies noted above. OJP will communicate with these and other agencies, as needed, to inform the grant-making process, prevent duplication across federal funding sources, and support the Administration’s goals with respect to substance abuse and diversion.

The Objectives and Deliverables are directly related to the performance measures that demonstrate the results of the work completed, as discussed in Section D. Application and Submission Information, under “Program Narrative.”

Evidence-based Programs or Practices OJP strongly emphasizes the use of data and evidence in policy making and program development in criminal justice, juvenile justice, and crime victim services. OJP is committed to:

• Improving the quantity and quality of evidence OJP generates

• Integrating evidence into program, practice, and policy decisions within OJP and the field

• Improving the translation of evidence into practice

OJP considers programs and practices to be evidence-based when their effectiveness has been demonstrated by causal evidence, generally obtained through one or more outcome evaluations. Causal evidence documents a relationship between an activity or intervention (including technology) and its intended outcome, including measuring the direction and size of a change, and the extent to which a change may be attributed to the activity or intervention. Causal evidence depends on the use of scientific methods to rule out, to the extent possible, alternative explanations for the documented change. The strength of causal evidence, based on the factors described above, will influence the degree to which OJP considers a program or practice to be evidence-based.

The OJP CrimeSolutions.gov website at https://www.crimesolutions.gov is one resource that applicants may use to find information about evidence-based programs in criminal justice, juvenile justice, and crime victim services.

Collaborative partnerships between researchers and practitioners have great potential to improve practice and policy. The National Institute of Justice published findings of the Research-Practitioner Partnerships Study, which documents, synthesizes, and shares what makes partnerships between researchers and practitioners successful. Access the findings at http://www.ncjrs.gov/pdffiles1/nij/grants/243911.pdf.

For information related to implementation science, applicants may wish to refer to the National Implementation Research Network website at http://nirn.fpg.unc.edu/.

Information Regarding Potential Evaluation of Programs and Activities The Department of Justice has prioritized the use of evidence-based programming and deems it critical to continue to build and expand the evidence informing criminal and juvenile justice programs to reach the highest level of rigor possible. Therefore, applicants should note that the Office of Justice Programs may conduct or support an evaluation of the programs and activities funded under this solicitation. Recipients and sub-recipients will be expected to cooperate with program-related assessments or evaluation efforts, including through the collection and provision of information or data requested by OJP (or its designee) for the assessment or evaluation of any activities and/or outcomes of those activities funded under this solicitation.

https://www.crimesolutions.gov/ http://www.ncjrs.gov/pdffiles1/nij/grants/243911.pdf http://nirn.fpg.unc.edu/

The information or data requested may be in addition to any other financial or performance data already required under this program.

Encouraging Program Investments in Economically-Distressed Communities (Qualified Opportunity Zones) Under Category 1 of this program, OJP will, as appropriate and as allowed under the distribution requirements of 34 U.S.C. 10704, give priority consideration in award decisions to applications that propose projects that directly benefit federally designated Qualified Opportunity Zones (QOZ).2 In order to assist OJP in considering this factor, applicants should include information in the application that specifies how the project will enhance public safety in the specified QOZs.

For resources on QOZs, and for a current list of designated QOZs, see the U.S. Department of the Treasury’s resource webpage, accessible at https://www.cdfifund.gov/pages/opportunity-zones.aspx.

B. Federal Award Information

Type of Award BJA expects to make up to 80 awards for varying amounts and performance periods, depending on the category or subcategory under which the application is awarded (see below). BJA anticipates that over half of these awards will be funded by the CARA appropriation and the remaining awards will be funded under the Harold Rogers Prescription Drug Monitoring Program. All performance periods should begin on or after October 1, 2019.

BJA may, in certain cases, provide additional funding in future years to awards made under this solicitation, through continuation awards. In making decisions regarding continuation awards, OJP will consider, among other factors, the availability of appropriations, when the program or project was last competed, OJP’s strategic priorities, and OJP’s assessment of both the management of the award (for example, timeliness and quality of progress reports), and the progress of the work funded under the award.

All awards are subject to the availability of appropriated funds and to any modifications or additional requirements that may be imposed by law.

Category 1: Locally Driven Responses to the Opioid Epidemic. Project period: 36 months. Competition ID: BJA-2019-15112.

The maximum award amount available is based on the population of the proposed community to be served as described below.

Subcategory 1a – An urban area or large county with a population greater than 500,000.

The maximum award available for Category 1a is $1,200,000 for the entire grant period.

Subcategory 1b – A suburban area or medium-size county with a population between 100,000 and 500,000. The maximum award available for Category 1b is $900,000 for the entire grant period.

Subcategory 1c – A rural area or small county with a population of fewer than 100,000 or a federally recognized Indian tribe. The maximum award available for Category 1c is $600,000 for the entire grant period

2 See Public Law 115-97, Title I, Subtitle C, Part IX, Subpart B, Sec. 13823.

https://www.cdfifund.gov/pages/opportunity-zones.aspx https://www.cdfifund.gov/pages/opportunity-zones.aspx

Category 2: Statewide Implementation, Enhancement and Evaluation Projects. Project period: 36 months. Competition ID: BJA-2019-15090.

Applicants may apply for Subcategory 2a (projects to be implemented in 3 to 5 sites may request up to $3,000,000; projects to be implemented in 6 or more sites may request up to $5,000,000) for up to a 36-month period; Subcategory 2b (projects to be implemented in 3 or more sites may request up to $1,500,000) for up to a 36-month period; or Subcategory 2c (up to $6,500,000) for up to a 36-month period.

Category 3: Harold Rogers Prescription Drug Monitoring Program (PDMP) Implementation and Enhancement Projects. Project period: 36 months. Competition ID:

BJA-2019-15091.

Applicants under Category 3 may request a project period of 36 months and an award amount no greater than $2,000,000. The application budget must reflect the total requested funding amount for the entire grant period.

Categories 1 and 2: Type of Award BJA expects that any award under this solicitation in these categories will be made in the form of a cooperative agreement, which is a type of award that provides for OJP to have substantial involvement in carrying out award activities. See Administrative, National Policy, and Other Legal Requirements, under Section F. Federal Award Administration Information, for a brief discussion of what may constitute substantial federal involvement.

Category 3: Type of Award BJA expects that any award under this solicitation will be made in the form of a grant. See Administrative, National Policy, and Other Legal Requirements, under Section F. Federal Award Administration Information, for a brief discussion of important statutes, regulations, and award conditions that apply to many (or in some cases, all) OJP grants.

Priority Considerations for Categories 1 and 2 Priority consideration will be given to applicants that:

• Demonstrate the state, or regions within the state, have been disproportionately impacted by the abuse of illicit opioids and prescription drugs as evidenced, in part, by high rates of primary treatment admissions; high rates of overdose deaths from heroin and other opioids; and/or a lack of accessibility to treatment providers and facilities and to emergency medical services.

• Include a research partner that will assist in the identification of the problem, design of the solution, and evaluation of the proposed initiative.

• Incorporate the use of Overdose Detection Mapping Application Program (ODMAP) data collection tools to track near real-time fatal and non-fatal overdose data. This information is designed to facilitate public safety, behavioral health, and/or public health partnerships, and help inform prevention, outreach, treatment and enforcement initiatives. Communities with existing data tracking systems that capture fatal and non-fatal overdose data can receive priority consideration by agreeing to also make data available through ODMAP.

• Propose projects in Categories 1 and 2a that are not current BJA COAP-funded sites. A list of these current BJA COAP-funded sites may be found at https://www.coapresources.org/.

https://www.coapresources.org/

Priority Considerations for Category 3 Priority consideration will be given to applicants that have pending or enacted state legislation that:

• Requires licensed prescribers to register with the PDMP.

• Requires prescribers to query the PDMP before prescribing drugs in Schedules II, III, and IV.

• Allows the PDMP to proactively analyze their data.

• Requires interstate data sharing of PDMP data.

• Allows law enforcement access to the PDMP based on an open investigation.

• Allows unsolicited reports to be sent to regulatory/licensing boards and law enforcement.

Financial Management and System of Internal Controls Award recipients and subrecipients (including recipients or subrecipients that are pass-through entities3) must, as described in the Part 200 Uniform Requirements4 as set out at 2 C.F.R.

200.303:

(a) Establish and maintain effective internal control over the Federal award that provides reasonable assurance that [the recipient (and any subrecipient)] is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States and the “Internal Control Integrated Framework”, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

(b) Comply with Federal statutes, regulations, and the terms and conditions of the Federal awards.

(c) Evaluate and monitor [the recipient’s (and any subrecipient’s)] compliance with statutes, regulations, and the terms and conditions of Federal awards.

(d) Take prompt action when instances of noncompliance are identified including noncompliance identified in audit findings.

(e) Take reasonable measures to safeguard protected personally identifiable information and other information the Federal awarding agency or pass-through entity designates as sensitive or [the recipient (or any subrecipient)] considers sensitive consistent with applicable Federal, state, local, and tribal laws regarding privacy and obligations of confidentiality.

To help ensure that applicants understand the applicable administrative requirements and cost principles, OJP encourages prospective applicants to enroll, at no charge, in the DOJ Grants

3 For purposes of this solicitation, the phrase “pass-through entity” includes any recipient or subrecipient that provides a subaward ("subgrant”) to a subrecipient (“subgrantee”) to carry out part of the funded award or program.

4 The "Part 200 Uniform Requirements” means the DOJ regulation at 2 C.F.R Part 2800, which adopts (with certain modifications) the provisions of 2 C.F.R. Part 200.

Financial Management Online Training, available at https://onlinegfmt.training.ojp.gov. (This training is required for all OJP award recipients.)

Also, applicants should be aware that OJP collects information from applicants on their financial management and systems of internal controls (among other information) which is used to make award decisions. Under Section D. Application and Submission Information, applicants may access and review a questionnaire—the OJP Financial Management and System of Internal Controls Questionnaire—that OJP requires all applicants (other than an individual applying in his/her personal capacity) to download, complete, and submit as part of the application.

Budget Information The budget must explicitly describe how the proposed budget items directly apply to the project design and will assist the applicant in meeting the project objectives.

For all Categories, no more than 10 percent of the budget may be used for costs incurred to administer the grant, including administrative costs that are included in an indirect cost rate agreement (see page 24 for more information). Note that expenses involved with the direct implementation of project objectives are not considered administrative for the purpose of this limitation.

Cost Sharing or Match Requirement This solicitation does not require a match. However, if a successful application proposes a voluntary match amount, and OJP approves the budget, the total match amount incorporated into the approved budget becomes mandatory and subject to audit.

For additional information on cost sharing and match, see the DOJ Grants Financial Guide at https://ojp.gov/financialguide/DOJ/PostawardRequirements/chapter3.3b.htm.

Pre-agreement Costs (also known as Pre-award Costs) Pre-agreement costs are costs incurred by the applicant prior to the start date of the period of performance of the federal award.

OJP does not typically approve pre-agreement costs; an applicant must request and obtain the prior written approval of OJP for all such costs. All such costs incurred prior to award and prior to approval of the costs are incurred at the sole risk of the applicant. (Generally, no applicant should incur project costs before submitting an application requesting federal funding for those costs.) Should there be extenuating circumstances that make it appropriate for OJP to consider approving pre-agreement costs, the applicant may contact the point of contact listed on the title page of this solicitation for the requirements concerning written requests for approval. If approved in advance by OJP, award funds may be used for pre-agreement costs, consistent with the recipient’s approved budget and applicable cost principles. See the section on Costs Requiring Prior Approval in the DOJ Grants Financial Guide at https://ojp.gov/financialguide/DOJ/index.htm for more information.

Limitation on Use of Award Funds for Employee Compensation; Waiver With respect to any award of more than $250,000 made under this solicitation, a recipient may not use federal funds to pay total cash compensation (salary plus cash bonuses) to any employee of the recipient at a rate that exceeds 110 percent of the maximum annual salary payable to a member of the federal government’s Senior Executive Service (SES) at an agency https://onlinegfmt.training.ojp.gov/ https://ojp.gov/funding/Apply/Resources/FinancialCapability.pdf https://ojp.gov/funding/Apply/Resources/FinancialCapability.pdf https://ojp.gov/financialguide/DOJ/PostawardRequirements/chapter3.3b.htm https://ojp.gov/financialguide/DOJ/index.htm with a Certified SES Performance Appraisal System for that year.5 The 2019 salary table for SES employees is available on the Office of Personnel Management website at https://www.opm.gov/policy-data-oversight/pay-leave/salaries-wages/salary-tables/19Tables/exec/html/ES.aspx. Note: A recipient may compensate an employee at a greater rate, provided the amount in excess of this compensation limitation is paid with non-federal funds. (Non-federal funds used for any such additional compensation will not be considered matching funds, where match requirements apply.) If only a portion of an employee's time is charged to an OJP award, the maximum allowable compensation is equal to the percentage of time worked times the maximum salary limitation.

The Assistant Attorney General for OJP may exercise discretion to waive, on an individual basis, the limitation on compensation rates allowable under an award. An applicant that requests a waiver should include a detailed justification in the budget narrative of its application.

An applicant that does not submit a waiver request and justification with its application should anticipate that OJP will require the applicant to adjust and resubmit the budget.

The justification should address, in the context of the work the individual would do under the award, the particular qualifications and expertise of the individual, the uniqueness of a service the individual will provide, the individual’s specific knowledge of the proposed program or project, and a statement that explains whether and how the individual’s salary under the award would be commensurate with the regular and customary rate for an individual with his/her qualifications and expertise, and for the work he/she would do under the award.

Prior Approval, Planning, and Reporting of Conference/Meeting/Training Costs OJP strongly encourages every applicant that proposes to use award funds for any conference-, meeting-, or training-related activity (or similar event) to review carefully—before submitting an application—the OJP and DOJ policy and guidance on approval, planning, and reporting of such events, available at www.ojp.gov/financialguide/DOJ/PostawardRequirements/chapter3.10a.htm. OJP policy and guidance (1) encourage minimization of conference, meeting, and training costs; (2) require prior written approval (which may affect project timelines) of most conference, meeting, and training costs for cooperative agreement recipients and of some conference, meeting, and training costs for grant recipients; and (3) set cost limits, including a general prohibition of all food and beverage costs.

Costs Associated with Language Assistance (if applicable) If an applicant proposes a program or activity that would deliver services or benefits to individuals, the costs of taking reasonable steps to provide meaningful access to those services or benefits for individuals with limited English proficiency may be allowable. Reasonable steps to provide meaningful access to services or benefits may include interpretation or translation services where appropriate.

For additional information, see the "Civil Rights Compliance" section under “Overview of Legal Requirements Generally Applicable to OJP Grants and Cooperative Agreements - FY 2018 Awards” in the OJP Funding Resource Center at https://ojp.gov/funding/index.htm.

C. Eligibility Information

For eligibility information, see title page.

5 OJP does not apply this limitation on the use of award funds to the nonprofit organizations listed in Appendix VIII to 2 C.F.R. Part 200.

https://www.opm.gov/policy-data-oversight/pay-leave/salaries-wages/salary-tables/19Tables/exec/html/ES.aspx https://www.opm.gov/policy-data-oversight/pay-leave/salaries-wages/salary-tables/19Tables/exec/html/ES.aspx http://ojp.gov/financialguide/DOJ/PostawardRequirements/chapter3.10a.htm https://ojp.gov/funding/Explore/LegalOverview/index.htm https://ojp.gov/funding/Explore/LegalOverview/index.htm https://ojp.gov/funding/Explore/LegalOverview/index.htm https://ojp.gov/funding/index.htm

For information on cost sharing or match requirements, see Section B. Federal Award Information.

D. Application and Submission Information

What an Application Should Include This section describes in detail what an application should include. An applicant should anticipate that if it fails to submit an application that contains all of the specified project components, it may negatively affect the review of its application; and, should a decision be made to make an award, it may result in the inclusion of award conditions that preclude the recipient from accessing or using award funds until the recipient satisfies the conditions and OJP makes the funds available.

Moreover, an applicant should anticipate that an application that OJP determines is nonresponsive to the scope of the solicitation, or that OJP determines does not include the application elements that BJA has designated to be critical, will neither proceed to peer review, nor receive further consideration. For this solicitation, BJA has designated the following application elements as critical: Project Abstract, Program Narrative, Budget Detail Worksheet and Budget Narrative, Project Timeline, and Letters of Support or Interagency Agreements.

NOTE: OJP…